# The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients

> **NCT00261183** · PHASE3 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (—)

## Conditions studied

- Benzodiazepines

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT00261183
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 100 (—)
- **Last updated:** 2005-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261183, "The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00261183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*